{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:26:05Z","timestamp":1781526365496,"version":"3.54.1"},"reference-count":139,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372009"],"award-info":[{"award-number":["82372009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The incidence of thyroid cancer has increased markedly in recent years, largely driven by well-differentiated thyroid carcinoma (WDTC). WDTC is biologically heterogeneous, with generally favorable prognosis but substantial variability in clinical behavior. Advances in molecular imaging, artificial intelligence-assisted diagnostics, and liquid biopsy have altered diagnostic strategies, while targeted therapy and immunotherapy have expanded treatment options for selected patients with advanced disease. The multidisciplinary team (MDT) model has therefore become an essential component of WDTC management through the integration of expertise from multiple specialties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This review examines the role of MDT application in WDTC through analysis of relevant literature and international clinical guidelines, focusing on MDT composition, implementation models, clinical roles across diagnostic and therapeutic pathways, and current limitations. Differences in MDT recommendations among guidelines from various regions were also compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MDT involvement supports personalized decision-making in WDTC, particularly in cases with indeterminate diagnosis, risk-adapted treatment selection, recurrent disease, and radioiodine-refractory progression. Persistent challenges include overtreatment of low-risk disease, suboptimal management of high-risk cases, limited MDT implementation in primary hospitals, uneven specialty participation, and variability in decision-making within guideline gray zones.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The MDT model provides a structured framework to improve risk-adapted management of WDTC. Future efforts should prioritize refined risk-stratified MDT models, integration of decision-support tools, and expansion of remote platforms to enhance consistency and quality of management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/oncolo\/oyag017","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:26:13Z","timestamp":1770035173000},"source":"Crossref","is-referenced-by-count":4,"title":["Multidisciplinary team diagnosis and treatment of well-differentiated thyroid carcinoma: current landscape and future prospects"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1029-2592","authenticated-orcid":false,"given":"Yuanyuan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, First Hospital of Shanxi Medical University , Taiyuan, 030001,","place":["China"]},{"name":"Shanxi Key Laboratory of Molecular Imaging, Shanxi Medical University , Taiyuan, 030001,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5757-776X","authenticated-orcid":false,"given":"Peijie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, First Hospital of Shanxi Medical University , Taiyuan, 030001,","place":["China"]},{"name":"Shanxi Key Laboratory of Molecular Imaging, Shanxi Medical University , Taiyuan, 030001,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8041-7955","authenticated-orcid":false,"given":"Jiaxin","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, First Hospital of Shanxi Medical University , Taiyuan, 030001,","place":["China"]},{"name":"Collaborative Innovation Center for Molecular Imaging of Precision Medicine, Shanxi Medical University , Taiyuan, 030001,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4961-4252","authenticated-orcid":false,"given":"Haiyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, First Hospital of Shanxi Medical University , Taiyuan, 030001,","place":["China"]},{"name":"Collaborative Innovation Center for Molecular Imaging of Precision Medicine, Shanxi Medical University , Taiyuan, 030001,","place":["China"]},{"name":"CAEA Center of Excellence on Nuclear Technology Applications for the Diagnosis, Treatment & Transformation of Nuclear Medicine , Taiyuan,\u00a0030001,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"2026022801264648000_oyag017-B1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026022801264648000_oyag017-B2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B3","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1089\/thy.2020.0038","article-title":"Patient-reported quality-of-life outcome measures in the thyroid cancer population","volume":"30","author":"Roth","year":"2020","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s12020-021-02786-y","article-title":"Distress, anxiety, depression and unmet needs in thyroid cancer survivors: a longitudinal study","volume":"74","author":"Dionisi-Vici","year":"2021","journal-title":"Endocrine"},{"key":"2026022801264648000_oyag017-B5","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/1097-0142(197503)35:3+&lt;876::aid-cncr2820350705&gt;3.0.co;2-8","article-title":"The multidiscipline team in a cancer center","volume":"35","author":"Murphy","year":"1975","journal-title":"Cancer"},{"key":"2026022801264648000_oyag017-B6","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.3390\/cancers13164159","article-title":"The effects of multidisciplinary team meetings on clinical practice for colorectal, lung, prostate and breast cancer: A systematic review","volume":"13","author":"Ko\u010do","year":"2021","journal-title":"Cancers"},{"key":"2026022801264648000_oyag017-B7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/jnci\/djad268","article-title":"The impact of multidisciplinary cancer conferences on overall survival: a meta-analysis","volume":"116","author":"Huang","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"2026022801264648000_oyag017-B8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer: a review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"key":"2026022801264648000_oyag017-B9","volume-title":"Thyroid Disease: Assessment and Management","author":"National Institute for Health and Care Excellence:","year":"2023"},{"key":"2026022801264648000_oyag017-B10","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/hed.27025","article-title":"American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: defining advanced thyroid cancer and its targeted treatment","volume":"44","author":"Shonka","year":"2022","journal-title":"Head Neck"},{"key":"2026022801264648000_oyag017-B11","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1089\/thy.2020.0826","article-title":"A joint statement from the American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, the Society of Nuclear Medicine and Molecular Imaging on current diagnostic and theranostic approaches in the management of thyroid cancer","volume":"31","author":"Gulec","year":"2021","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B12","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann Oncol"},{"key":"2026022801264648000_oyag017-B13","doi-asserted-by":"publisher","first-page":"e220027","DOI":"10.1530\/etj-22-0027","article-title":"Malignancy rates in thyroid nodules: A long-term cohort study of 17,592 patients","volume":"11","author":"Grussendorf","year":"2022","journal-title":"Eur Thyroid J"},{"key":"2026022801264648000_oyag017-B14","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1001\/jama.2017.0562","article-title":"Screening for thyroid cancer: updated evidence report and systematic review for the US preventive services task force","volume":"317","author":"Lin","year":"2017","journal-title":"JAMA"},{"key":"2026022801264648000_oyag017-B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3348\/kjr.2024.0963","article-title":"Radiofrequency ablation for recurrent thyroid cancers: 2025 Korean society of thyroid radiology guideline","volume":"26","author":"Ha","year":"2025","journal-title":"Korean J Radiol"},{"key":"2026022801264648000_oyag017-B17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1507\/endocrj.EJ24-0644","article-title":"The 2024 revised clinical guidelines on the management of thyroid tumors by the Japan association of endocrine surgery","volume":"72","author":"Sugitani","year":"2025","journal-title":"Endocr J"},{"key":"2026022801264648000_oyag017-B18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2214\/ajr.22.28556","article-title":"Diagnostic performance of six ultrasound risk stratification systems for thyroid nodules: a systematic review and network Meta-Analysis","volume":"220","author":"Kim","year":"2023","journal-title":"AJR Am J Roentgenol"},{"key":"2026022801264648000_oyag017-B19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1210\/jc.2018-01674","article-title":"Reducing the number of unnecessary thyroid biopsies while improving diagnostic accuracy: toward the \u201cright\u201d TIRADS","volume":"104","author":"Grani","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026022801264648000_oyag017-B20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2214\/ajr.20.24608","article-title":"Update on ACR TI-RADS: successes, challenges, and future directions, from the AJR special series on radiology reporting and data systems","volume":"216","author":"Hoang","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"2026022801264648000_oyag017-B21","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1007\/s10278-023-00884-z","article-title":"Improving the efficacy of ACR TI-RADS through deep learning-based descriptor augmentation","volume":"36","author":"Barinov","year":"2023","journal-title":"J Digit Imaging"},{"key":"2026022801264648000_oyag017-B22","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.1007\/s00330-022-09378-y","article-title":"Clinical value of artificial intelligence in thyroid ultrasound: a prospective study from the real world","volume":"33","author":"Li","year":"2023","journal-title":"Eur Radiol"},{"key":"2026022801264648000_oyag017-B23","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.1016\/s2589-7500(21)00041-8","article-title":"Deep learning-based artificial intelligence model to assist thyroid nodule diagnosis and management: a multicentre diagnostic study","volume":"3","author":"Peng","year":"2021","journal-title":"Lancet Digit Health"},{"key":"2026022801264648000_oyag017-B24","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1016\/j.acra.2024.07.053","article-title":"Radiomics combined with ACR TI-RADS for thyroid nodules: diagnostic performance, unnecessary biopsy rate, and nomogram construction","volume":"31","author":"Zhang","year":"2024","journal-title":"Acad Radiol"},{"key":"2026022801264648000_oyag017-B25","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1089\/thy.2023.0132","article-title":"Artificial intelligence in thyroidology: a narrative review of the current applications, associated challenges, and future directions","volume":"33","author":"Toro-Tobon","year":"2023","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B26","doi-asserted-by":"publisher","first-page":"e221408","DOI":"10.1148\/radiol.221408","article-title":"Multimodality US versus thyroid imaging reporting and data system criteria in recommending fine-needle aspiration of thyroid nodules","volume":"307","author":"Xiao","year":"2023","journal-title":"Radiology"},{"key":"2026022801264648000_oyag017-B27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1148\/radiol.212319","article-title":"A practical CEUS thyroid reporting system for thyroid nodules","volume":"305","author":"Ruan","year":"2022","journal-title":"Radiology"},{"key":"2026022801264648000_oyag017-B28","doi-asserted-by":"publisher","first-page":"845549","DOI":"10.3389\/fonc.2022.845549","article-title":"US-elastography with different techniques for thyroid nodule characterization: systematic review and meta-analysis","volume":"12","author":"Cantisani","year":"2022","journal-title":"Front Oncol"},{"key":"2026022801264648000_oyag017-B29","doi-asserted-by":"publisher","first-page":"e221465","DOI":"10.1148\/radiol.221465","article-title":"Contrast-enhanced US with perfluorobutane to diagnose small lateral cervical lymph node metastases of papillary thyroid carcinoma","volume":"307","author":"Xiao","year":"2023","journal-title":"Radiology"},{"key":"2026022801264648000_oyag017-B30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11154-023-09841-1","article-title":"Thyroid ultrasound and its ancillary techniques","volume":"25","author":"Bojunga","year":"2024","journal-title":"Rev Endocr Metab Disord"},{"key":"2026022801264648000_oyag017-B31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/jamaoto.2021.3387","article-title":"Diagnostic test \u00adaccuracy\u00a0of\u00a0ultrasonography vs computed tomography for \u00adpapillary\u00a0thyroid cancer cervical lymph node metastasis: a \u00adsystematic review and meta-analysis","volume":"148","author":"Alabousi","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2026022801264648000_oyag017-B32","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1186\/s12885-024-13288-1","article-title":"The evolving role of MRI in the detection of extrathyroidal extension of papillary thyroid carcinoma: a systematic review and meta-analysis","volume":"24","author":"Javid","year":"2024","journal-title":"BMC Cancer"},{"key":"2026022801264648000_oyag017-B33","doi-asserted-by":"publisher","first-page":"154516","DOI":"10.1016\/j.prp.2023.154516","article-title":"Preoperative evaluation of thyroid nodules \u2013 diagnosis and management strategies","volume":"246","author":"Antonia","year":"2023","journal-title":"Pathol Res Pract"},{"key":"2026022801264648000_oyag017-B34","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1089\/thy.2019.0575","article-title":"Combining the American thyroid association\u2019s ultrasound classification with cytological subcategorization improves the assessment of malignancy risk in indeterminate thyroid nodules","volume":"31","author":"Larcher de Almeida","year":"2021","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B35","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1089\/thy.2024.0481","article-title":"Development of a nomogram to integrate molecular testing and clinical variables to improve malignancy risk assessment among cytologically indeterminate thyroid nodules","volume":"35","author":"Wu","year":"2025","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B36","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1210\/clinem\/dgac537","article-title":"Clinical use of Raman spectroscopy improves diagnostic accuracy for indeterminate thyroid nodules","volume":"107","author":"Palermo","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026022801264648000_oyag017-B37","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1089\/thy.2023.0255","article-title":"Prospective validation of ThyroSPEC molecular testing of indeterminate thyroid nodule cytology following diagnostic pathway optimization","volume":"33","author":"Stewardson","year":"2023","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B38","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1002\/hed.27472","article-title":"European experience with the Afirma gene expression classifier for indeterminate thyroid nodules: a clinical utility study in the Netherlands","volume":"45","author":"Lon\u010dar","year":"2023","journal-title":"Head Neck"},{"key":"2026022801264648000_oyag017-B39","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/cncy.22829","article-title":"The role of the ThyGeNEXT oncogene panel used in combination with the expanded miRNA panel ThyraMIRv2 in indeterminate thyroid nodules: a large, blinded, real-world, observational study","volume":"132","author":"Verma","year":"2024","journal-title":"Cancer Cytopathol"},{"key":"2026022801264648000_oyag017-B40","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1210\/clinem\/dgad220","article-title":"Molecular profiling of 50 734 Bethesda III-VI thyroid nodules by ThyroSeq v3: Implications for personalized management","volume":"108","author":"Chiosea","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026022801264648000_oyag017-B41","doi-asserted-by":"publisher","first-page":"e458","DOI":"10.1016\/s2589-7500(24)00085-2","article-title":"Deep learning models for thyroid nodules diagnosis of fine-needle aspiration biopsy: a retrospective, prospective, multicentre study in China","volume":"6","author":"Wang","year":"2024","journal-title":"Lancet Digit Health"},{"key":"2026022801264648000_oyag017-B42","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1089\/thy.2023.0384","article-title":"Improved diagnostic accuracy of thyroid fine-needle aspiration cytology with artificial intelligence technology","volume":"34","author":"Lee","year":"2024","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B43","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s40618-024-02467-3","article-title":"Serum microRNA-146a-5p and microRNA-221-3p as potential clinical biomarkers for papillary thyroid carcinoma","volume":"48","author":"Verrienti","year":"2025","journal-title":"J Endocrinol Invest"},{"key":"2026022801264648000_oyag017-B44","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41416-024-02575-0","article-title":"Circulating small extracellular vesicle-based miRNA classifier for follicular thyroid carcinoma: a diagnostic study","volume":"130","author":"Li","year":"2024","journal-title":"Br J Cancer"},{"key":"2026022801264648000_oyag017-B45","doi-asserted-by":"publisher","first-page":"e230002","DOI":"10.1530\/erc-23-0002","article-title":"Liquid biopsies in thyroid cancers: A systematic review and meta-analysis","volume":"30","author":"Zeyghami","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"2026022801264648000_oyag017-B46","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1210\/clinem\/dgad335","article-title":"Diagnostic efficacy of FNA-Tg in DTC cervical LN metastasis and its impact factors: a large retrospective study","volume":"108","author":"Liu","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026022801264648000_oyag017-B47","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.eprac.2021.02.005","article-title":"Diagnostic role of cell-free DNA integrity in thyroid cancer particularly for Bethesda IV cytology","volume":"27","author":"Higazi","year":"2021","journal-title":"Endocr Pract"},{"key":"2026022801264648000_oyag017-B48","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fendo.2019.00421","article-title":"Leukocyte mitochondrial DNA copy number and risk of thyroid cancer: a two-stage case-control study","volume":"10","author":"Zheng","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026022801264648000_oyag017-B49","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1089\/thy.2023.0076","article-title":"Long-term outcomes of active surveillance and immediate surgery for adult patients with low-risk papillary thyroid microcarcinoma: 30-year experience","volume":"33","author":"Miyauchi","year":"2023","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B50","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1089\/thy.2023.0634","article-title":"Decision regret following the choice of surgery or active surveillance for small, low-risk papillary thyroid cancer: a prospective cohort study","volume":"34","author":"Sawka","year":"2024","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B51","doi-asserted-by":"publisher","first-page":"7942","DOI":"10.1007\/s00330-023-09802-x","article-title":"Safety and efficacy of microwave ablation for the treatment of low-risk papillary thyroid microcarcinoma: a prospective multicenter study","volume":"33","author":"Han","year":"2023","journal-title":"Eur Radiol"},{"key":"2026022801264648000_oyag017-B52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/jamaoto.2021.4381","article-title":"Assessment of radiofrequency ablation for papillary microcarcinoma of the thyroid: a systematic review and meta-analysis","volume":"148","author":"van Dijk","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2026022801264648000_oyag017-B53","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1089\/thy.2021.0100","article-title":"Ultrasound-guided radiofrequency ablation versus thyroid lobectomy for low-risk papillary thyroid microcarcinoma: a propensity-matched cohort study of 884 patients","volume":"31","author":"Yan","year":"2021","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1001\/jamasurg.2022.5781","article-title":"Comparison of lobectomy vs total thyroidectomy for Intermediate-risk papillary thyroid carcinoma with lymph node metastasis","volume":"158","author":"Xu","year":"2023","journal-title":"JAMA Surg"},{"key":"2026022801264648000_oyag017-B55","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1001\/jamaoto.2024.3860","article-title":"Lobectomy vs total thyroidectomy with ipsilateral lateral neck dissection for N1b intermediate-risk papillary thyroid carcinoma","volume":"151","author":"Saito","year":"2025","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2026022801264648000_oyag017-B56","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s11136-020-02676-2","article-title":"A systematic review of health state utility values for thyroid cancer","volume":"30","author":"Houten","year":"2021","journal-title":"Qual Life Res"},{"key":"2026022801264648000_oyag017-B57","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1089\/thy.2023.0328","article-title":"Health-related quality of life in patients with low-risk differentiated thyroid cancer: a systematic review examining the extent of thyroidectomy","volume":"34","author":"Bach","year":"2024","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B58","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/wjs.12012","article-title":"A comparison of swallowing related quality of life in patients undergoing transoral endoscopic versus open thyroid surgery","volume":"48","author":"Deshmukh","year":"2024","journal-title":"World J Surg"},{"key":"2026022801264648000_oyag017-B59","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1245\/s10434-022-13020-y","article-title":"Five-year oncologic outcome and surgical completeness of transoral robotic thyroidectomy for papillary thyroid carcinoma: comparison with conventional transcervical thyroidectomy using propensity score matching","volume":"30","author":"Lee","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"2026022801264648000_oyag017-B60","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/js9.0000000000002071","article-title":"Observational cohort study on safety and efficacy of robotic thyroidectomy with super-meticulous capsular dissection versus open surgery for thyroid cancer: postoperative dynamic risk assessment of radioactive iodine therapy","volume":"111","author":"Qin","year":"2025","journal-title":"Int J Surg. (London, England)"},{"key":"2026022801264648000_oyag017-B61","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1007\/s00464-025-11568-w","article-title":"Implications of five endoscopic and conventional open surgery on lateral neck dissection outcomes in patients with papillary thyroid carcinoma: a network meta-analysis and systematic review","volume":"39","author":"Tong","year":"2025","journal-title":"Surg Endosc"},{"key":"2026022801264648000_oyag017-B62","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/js9.0000000000001970","article-title":"Effectiveness and feasibility of nerve real-time monitoring and intermittent monitoring in endoscopic thyroidectomy: a multicenter retrospective cohort study of 1621 patients","volume":"111","author":"Yu","year":"2025","journal-title":"Int J Surg. (London, England)"},{"key":"2026022801264648000_oyag017-B63","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/ohn.1162","article-title":"Communication of voice-related complications in thyroidectomy: a qualitative analysis","volume":"172","author":"Kao","year":"2025","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2026022801264648000_oyag017-B64","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1097\/rlu.0000000000005022","article-title":"Comparison of recombinant human thyroid-stimulating hormone and thyroid hormone withdrawal for 131 I therapy in patients with intermediate- to high-risk thyroid cancer: a systematic review and meta-analysis","volume":"49","author":"Park","year":"2024","journal-title":"Clin Nucl Med"},{"key":"2026022801264648000_oyag017-B65","doi-asserted-by":"publisher","first-page":"106280","DOI":"10.1016\/j.oraloncology.2022.106280","article-title":"Effect of recombinant human thyroid stimulating hormone on long-term salivary gland dysfunction in thyroid cancer patients treated with radioactive iodine. A systematic review","volume":"136","author":"Sunavala-Dossabhoy","year":"2023","journal-title":"Oral Oncol"},{"key":"2026022801264648000_oyag017-B66","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/s0140-6736(25)00629-4","article-title":"Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial","volume":"406","author":"Mallick","year":"2025","journal-title":"Lancet (London, England)"},{"key":"2026022801264648000_oyag017-B67","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/s2213-8587(24)00276-6","article-title":"Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial","volume":"13","author":"Leboulleux","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026022801264648000_oyag017-B68","doi-asserted-by":"publisher","first-page":"1442714","DOI":"10.3389\/fendo.2024.1442714","article-title":"Comparing therapeutic outcomes: radioactive iodine therapy versus non-radioactive iodine therapy in differentiated thyroid cancer","volume":"15","author":"Tiuc\u0103","year":"2024","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"2026022801264648000_oyag017-B69","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1001\/jamaoto.2021.0288","article-title":"Radioiodine remnant ablation for differentiated thyroid cancer: a systematic review and meta-analysis","volume":"147","author":"James","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2026022801264648000_oyag017-B70","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s00259-020-05020-5","article-title":"How to better stratify the risk of differentiated thyroid carcinomas: the key role of radioactive iodine therapy, age, and gender","volume":"48","author":"Piccardo","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026022801264648000_oyag017-B71","doi-asserted-by":"publisher","first-page":"933648","DOI":"10.3389\/fphar.2022.933648","article-title":"Efficacy and safety of targeted therapeutics for patients with radioiodine-refractory differentiated thyroid cancer: systematic review and network meta-analysis","volume":"13","author":"Ji","year":"2022","journal-title":"Front \u00adPharmacol"},{"key":"2026022801264648000_oyag017-B72","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1210\/clinem\/dgae617","article-title":"Efficacy and safety of targeted therapy for radioiodine-refractory differentiated thyroid cancer","volume":"110","author":"Zhang","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026022801264648000_oyag017-B73","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/jcm14020338","article-title":"The efficacy and safety of anlotinib in the treatment of thyroid cancer: A systematic review","volume":"14","author":"Muntean","year":"2025","journal-title":"JCM"},{"key":"2026022801264648000_oyag017-B74","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1089\/thy.2022.0061","article-title":"Multikinase inhibitors for the treatment of asymptomatic radioactive iodine-refractory differentiated thyroid cancer: global noninterventional study (RIFTOS MKI)","volume":"32","author":"Brose","year":"2022","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B75","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1089\/thy.2023.0363","article-title":"Pralsetinib in patients with advanced\/metastatic rearranged during transfection (RET)-altered thyroid cancer: updated efficacy and safety data from the ARROW study","volume":"34","author":"Subbiah","year":"2024","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B76","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1210\/clinem\/dgae454","article-title":"Efficacy and safety of multikinase inhibitors for patients with refractory thyroid cancer: systematic review and network meta-analysis","volume":"109","author":"Jing","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026022801264648000_oyag017-B77","doi-asserted-by":"publisher","DOI":"10.1530\/erc-24-0219","article-title":"Efficacy and safety of RET-kinase inhibitors in RET-altered thyroid cancers: a systematic review and single-arm meta-analysis","volume":"32","author":"Riya","year":"2025","journal-title":"Endocr Relat Cancer"},{"key":"2026022801264648000_oyag017-B78","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1089\/thy.2022.0115","article-title":"Dabrafenib versus dabrafenib + trametinib in BRAF-Mutated radioactive iodine refractory differentiated thyroid cancer: results of a randomized, phase 2, open-label multicenter trial","volume":"32","author":"Busaidy","year":"2022","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B79","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1158\/1078-0432.Ccr-23-0046","article-title":"A phase II redifferentiation trial with dabrafenib-trametinib and 131I in metastatic radioactive iodine refractory BRAF p.V600E-Mutated differentiated thyroid cancer","volume":"29","author":"Leboulleux","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2026022801264648000_oyag017-B80","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1001\/jamaoncol.2024.4019","article-title":"Dual immune checkpoint inhibition in patients with aggressive thyroid carcinoma: a phase 2 nonrandomized clinical trial","volume":"10","author":"Sehgal","year":"2024","journal-title":"JAMA Oncol"},{"key":"2026022801264648000_oyag017-B81","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1210\/clinem\/dgab731","article-title":"A randomized study of lenvatinib 18 mg vs 24 mg in patients with radioiodine-refractory differentiated thyroid cancer","volume":"107","author":"Brose","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026022801264648000_oyag017-B82","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJMoa1406470","article-title":"Lenvatinib versus placebo in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger","year":"2015","journal-title":"N Engl J Med"},{"key":"2026022801264648000_oyag017-B83","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/thy.2022.0054","article-title":"Lenvatinib compared with sorafenib as a first-line treatment for radioactive iodine-refractory, progressive, differentiated thyroid carcinoma: real-world outcomes in a multicenter retrospective cohort study","volume":"33","author":"Kim","year":"2023","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B84","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1089\/thy.2023.0463","article-title":"Increased progression-free survival with cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer irrespective of prior vascular endothelial growth factor receptor-targeted therapy and tumor histology: a subgroup analysis of the cosmic-311 study","volume":"34","author":"Capdevila","year":"2024","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B85","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/s2213-8587(25)00064-6","article-title":"Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an international thyroid oncology group statement","volume":"13","author":"Leboulleux","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026022801264648000_oyag017-B86","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1200\/jco.23.02503","article-title":"Durability of response with selpercatinib in patients with RET-Activated thyroid cancer: long-term safety and efficacy from LIBRETTO-001","volume":"42","author":"Wirth","year":"2024","journal-title":"J Clin Oncol"},{"key":"2026022801264648000_oyag017-B87","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/s2213-8587(21)00120-0","article-title":"Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1\/2 study","volume":"9","author":"Subbiah","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026022801264648000_oyag017-B88","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1530\/eje-21-1259","article-title":"Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma","volume":"186","author":"Waguespack","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"2026022801264648000_oyag017-B89","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3390\/biom12030357","article-title":"Metformin and cancer hallmarks: Molecular mechanisms in thyroid, prostate and head and neck cancer models","volume":"12","author":"Morale","year":"2022","journal-title":"Biomolecules"},{"key":"2026022801264648000_oyag017-B90","doi-asserted-by":"publisher","first-page":"1304188","DOI":"10.3389\/fendo.2024.1304188","article-title":"Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab\/ipilimumab in poorly differentiated thyroid carcinoma with PTEN mutation: a case report and literature review","volume":"15","author":"Oh","year":"2024","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"2026022801264648000_oyag017-B91","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1158\/2159-8290.Cd-20-0735","article-title":"SWI\/SNF complex mutations promote thyroid tumor progression and insensitivity to redifferentiation therapies","volume":"11","author":"Saqcena","year":"2021","journal-title":"Cancer Discov"},{"key":"2026022801264648000_oyag017-B92","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1089\/thy.2024.0271","article-title":"The definition of recurrence of differentiated thyroid cancer: a systematic review of the literature","volume":"34","author":"van de Berg","year":"2024","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B93","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3348\/kjr.2024.0871","article-title":"Standardized ultrasound evaluation for active surveillance of Low-Risk thyroid microcarcinoma in adults: 2024 Korean society of thyroid radiology consensus statement","volume":"25","author":"Lee","year":"2024","journal-title":"Korean J Radiol"},{"key":"2026022801264648000_oyag017-B94","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3390\/diagnostics11081417","article-title":"Early predictive response to multi-tyrosine kinase inhibitors in advanced refractory radioactive-iodine differentiated thyroid cancer: A new challenge for [18F]FDG PET\/CT","volume":"11","author":"Ferrari","year":"2021","journal-title":"Diagnostics"},{"key":"2026022801264648000_oyag017-B95","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/cancers16040839","article-title":"FAPi-based agents in thyroid cancer: A new step towards diagnosis and therapy? a systematic review of the literature","volume":"16","author":"Guglielmo","year":"2024","journal-title":"Cancers"},{"key":"2026022801264648000_oyag017-B96","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00259-023-06404-z","article-title":"Head-to-head comparison of [(68)Ga]Ga-DOTA.SA.FAPi with [(18)F]F-FDG PET\/CT in radioiodine-resistant follicular-cell derived thyroid cancers","volume":"51","author":"Ballal","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026022801264648000_oyag017-B97","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.21037\/qims-24-2188","article-title":"Contribution of I-131 SPECT\/CT uptake on the dynamic risk assessment of papillary thyroid cancer","volume":"15","author":"Dom\u00ednguez-Ayala","year":"2025","journal-title":"Quant Imaging Med Surg"},{"key":"2026022801264648000_oyag017-B98","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1089\/thy.2021.0666","article-title":"Serum thyroglobulin measurement following surgery without radioactive iodine for differentiated thyroid cancer: a systematic review","volume":"32","author":"Chou","year":"2022","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B99","doi-asserted-by":"publisher","first-page":"e1377","DOI":"10.1210\/clinem\/dgae559","article-title":"Data-driven thyroglobulin cutoffs for low- and intermediate-risk thyroid cancer follow-up: ITCO real-world analysis","volume":"110","author":"Grani","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026022801264648000_oyag017-B100","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1089\/thy.2024.0330","article-title":"Association between serum thyrotropin and cancer recurrence in differentiated thyroid cancer: a population-based retrospective cohort study","volume":"35","author":"Qiang","year":"2025","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B101","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1097\/js9.0000000000001974","article-title":"Patient\u2011reported outcome measures for assessing health\u2011related quality of life in patients with differentiated thyroid cancer: a systematic review","volume":"111","author":"Xiong","year":"2025","journal-title":"Int J Surg. (London, England)"},{"key":"2026022801264648000_oyag017-B102","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1089\/thy.2023.0642","article-title":"Fear of cancer recurrence in differentiated thyroid cancer survivors: a systematic review","volume":"34","author":"Hampton","year":"2024","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ohn.1241","article-title":"Financial toxicity across the thyroid cancer care continuum: a systematic review","volume":"173","author":"Armache","year":"2025","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2026022801264648000_oyag017-B104","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/s1470-2045(21)00345-4","article-title":"Greater price transparency needed for thyroid cancer treatment among US cancer centres","volume":"22","author":"Nierengarten","year":"2021","journal-title":"Lancet Oncol"},{"key":"2026022801264648000_oyag017-B105","doi-asserted-by":"publisher","first-page":"100584","DOI":"10.1016\/j.apjon.2024.100584","article-title":"Benefit finding and its influencing factors in patients with thyroid cancer: a retrospective study","volume":"11","author":"Qian","year":"2024","journal-title":"Asia Pac J Oncol Nurs"},{"key":"2026022801264648000_oyag017-B106","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s12916-024-03652-0","article-title":"Effects of a mobile health intervention based on a multitheoretical model of health behavior change on anxiety and depression, fear of cancer progression, and quality of life in patients with differentiated thyroid cancer: a randomized controlled trial","volume":"22","author":"Sun","year":"2024","journal-title":"BMC Med"},{"key":"2026022801264648000_oyag017-B107","doi-asserted-by":"publisher","first-page":"e2246311","DOI":"10.1001\/jamanetworkopen.2022.46311","article-title":"Association between genetic risk, adherence to healthy lifestyle behavior, and thyroid cancer risk","volume":"5","author":"Feng","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026022801264648000_oyag017-B108","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s40618-022-01751-4","article-title":"Sleep quality, stress and thyroid cancer: a case-control study","volume":"45","author":"Afrashteh","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"2026022801264648000_oyag017-B109","doi-asserted-by":"publisher","first-page":"1173781","DOI":"10.3389\/fendo.2023.1173781","article-title":"Physical activity and reduced risk of fracture in thyroid cancer patients after thyroidectomy - a nationwide cohort study","volume":"14","author":"Kim","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026022801264648000_oyag017-B110","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.3390\/cancers15184502","article-title":"Role of prehabilitation and rehabilitation on functional recovery and quality of life in thyroid cancer patients: A comprehensive review","volume":"15","author":"Lippi","year":"2023","journal-title":"Cancers"},{"key":"2026022801264648000_oyag017-B111","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1007\/s00394-022-02897-w","article-title":"Inflammatory potential of the diet and association with risk of differentiated thyroid cancer in the European prospective investigation into cancer and nutrition (EPIC) cohort","volume":"61","author":"L\u00e9cuyer","year":"2022","journal-title":"Eur J Nutr"},{"key":"2026022801264648000_oyag017-B112","doi-asserted-by":"publisher","first-page":"e085631","DOI":"10.1136\/bmjopen-2024-085631","article-title":"Dietary pattern and risk of thyroid cancer: a systematic review and meta-analysis protocol","volume":"15","author":"Nagashima","year":"2025","journal-title":"BMJ Open"},{"key":"2026022801264648000_oyag017-B113","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1111\/dom.15746","article-title":"The interaction effect between BMI, diabetes and age at diabetes onset on the risk of thyroid cancer: a population-based cohort study in shanghai, China","volume":"26","author":"Hou","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2026022801264648000_oyag017-B114","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11154-023-09839-9","article-title":"The relationship between thyroid and human-associated microbiota: a systematic review of reviews","volume":"25","author":"Virili","year":"2024","journal-title":"Rev Endocr Metab Disord"},{"key":"2026022801264648000_oyag017-B115","doi-asserted-by":"publisher","first-page":"18823","DOI":"10.1038\/s41598-022-23549-3","article-title":"Sleep quality of patients with papillary thyroid carcinoma: a prospective longitudinal study with 5-year follow-up","volume":"12","author":"Koo","year":"2022","journal-title":"Sci Rep"},{"key":"2026022801264648000_oyag017-B116","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s00259-022-06072-5","article-title":"Gut microbiota is associated with response to (131)I therapy in patients with papillary thyroid carcinoma","volume":"50","author":"Zheng","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026022801264648000_oyag017-B117","doi-asserted-by":"publisher","first-page":"1602787","DOI":"10.3389\/fnut.2025.1602787","article-title":"Association between the newly proposed dietary index for gut microbiota and thyroid function: NHANES 2007-2012","volume":"12","author":"Peng","year":"2025","journal-title":"Front Nutr"},{"key":"2026022801264648000_oyag017-B118","doi-asserted-by":"publisher","first-page":"117912","DOI":"10.1016\/j.jep.2024.117912","article-title":"Anti-papillary thyroid carcinoma effects of Dioscorea bulbifera L. through ferroptosis and the PI3K\/AKT pathway based on network pharmacology and experimental validation","volume":"326","author":"Gao","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"2026022801264648000_oyag017-B119","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12906-023-03944-7","article-title":"Untargeted lipidomic analysis and network pharmacology for parthenolide treated papillary thyroid carcinoma cells","volume":"23","author":"Huang","year":"2023","journal-title":"BMC Complement Med Ther"},{"key":"2026022801264648000_oyag017-B120","doi-asserted-by":"publisher","first-page":"znae199","DOI":"10.1093\/bjs\/znae199","article-title":"European society of endocrine surgeons (ESES) consensus statement on advanced thyroid cancer: definitions and management","volume":"111","author":"Raffaelli","year":"2024","journal-title":"Br J Surg"},{"key":"2026022801264648000_oyag017-B121","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2147\/jmdh.S309953","article-title":"Thyroid cancer patients\u2019 view of clinician professionalism and multidisciplinary approach to their management","volume":"14","author":"D\u00edez","year":"2021","journal-title":"J Multidiscip Healthc"},{"key":"2026022801264648000_oyag017-B122","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1186\/s12913-022-08112-0","article-title":"Factors influencing the quality and functioning of oncological multidisciplinary team meetings: results of a systematic review","volume":"22","author":"Walraven","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"2026022801264648000_oyag017-B123","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.amjsurg.2021.07.013","article-title":"Influence of endocrine multidisciplinary tumor board on patient management and treatment decision making","volume":"223","author":"Kelley","year":"2022","journal-title":"Am J Surg"},{"key":"2026022801264648000_oyag017-B124","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.oraloncology.2019.02.020","article-title":"Quality insurance in head and neck cancer multidisciplinary team meetings: a watchful eye on real-life experience","volume":"91","author":"Guy","year":"2019","journal-title":"Oral Oncol"},{"key":"2026022801264648000_oyag017-B125","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.3390\/jcm10184150","article-title":"Variability in thyroid cancer multidisciplinary team meeting recommendations is not explained by standard variables: Outcomes of a single Centre review","volume":"10","author":"Fenton","year":"2021","journal-title":"JCM"},{"key":"2026022801264648000_oyag017-B126","doi-asserted-by":"publisher","first-page":"104267","DOI":"10.1016\/j.critrevonc.2024.104267","article-title":"Clinical decision support systems for multidisciplinary team decision-making in patients with solid cancer: composition of an implementation model based on a scoping review","volume":"195","author":"Hendriks","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026022801264648000_oyag017-B127","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/coa.14305","article-title":"Can artificial intelligence software be utilised for thyroid multi-disciplinary team outcomes?","volume":"50","author":"Habeeb","year":"2025","journal-title":"Clin Otolaryngol"},{"key":"2026022801264648000_oyag017-B128","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1186\/s12913-024-11984-z","article-title":"Understanding the effectiveness and quality of virtual cancer multidisciplinary team meetings (MDTMs): a systematic scoping review","volume":"24","author":"Onifade","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"2026022801264648000_oyag017-B129","doi-asserted-by":"publisher","first-page":"e250033","DOI":"10.6004\/jnccn.2025.0033","article-title":"NCCN guidelines\u00ae insights: thyroid carcinoma, version 1.2025","volume":"23","author":"Haddad","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"2026022801264648000_oyag017-B130","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3760\/cma.j.cn112142-20220421-00201","article-title":"[Chinese guideline on the diagnosis and treatment of thyroid-associated ophthalmopathy (2022)]","volume":"58","year":"2022","journal-title":"[Zhonghua Yan ke za Zhi] Chinese Journal of Ophthalmology"},{"key":"2026022801264648000_oyag017-B131","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/hed.26960","article-title":"Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: an international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association","volume":"44","author":"Orloff","year":"2022","journal-title":"Head Neck"},{"key":"2026022801264648000_oyag017-B132","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/thy.2018.0597","article-title":"Controversies, consensus, and collaboration in the use of (131)I therapy in differentiated thyroid cancer: a joint statement from the American thyroid association, the European association of nuclear medicine, the society of nuclear medicine and molecular imaging, and the European thyroid association","volume":"29","author":"Tuttle","year":"2019","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B133","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1089\/thy.2020.0330","article-title":"Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan association of endocrine surgery task force on management for papillary thyroid microcarcinoma","volume":"31","author":"Sugitani","year":"2021","journal-title":"Thyroid"},{"key":"2026022801264648000_oyag017-B134","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ejca.2022.11.005","article-title":"Position paper from the endocrine task force of the European Organisation for Research and Treatment of Cancer (EORTC) on the management and shared decision making in patients with low-risk micro papillary thyroid carcinoma","volume":"179","author":"Koot","year":"2023","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"key":"2026022801264648000_oyag017-B135","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3803\/EnM.2025.2461","article-title":"2025 Korean thyroid association clinical management guideline on active surveillance for Low-Risk papillary thyroid carcinoma","volume":"40","author":"Lee","year":"2025","journal-title":"Endocrinol Metab (Seoul, Korea)"},{"key":"2026022801264648000_oyag017-B136","doi-asserted-by":"publisher","first-page":"1437360","DOI":"10.3389\/fonc.2024.1437360","article-title":"Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodine-refractory thyroid carcinoma","volume":"14","author":"Ezzat","year":"2024","journal-title":"Front Oncol"},{"key":"2026022801264648000_oyag017-B137","doi-asserted-by":"publisher","DOI":"10.1530\/etj-25-0024","article-title":"Molecular predictive biomarker testing in advanced thyroid cancer - a European consensus","volume":"14","author":"Ry\u0161ka","year":"2025","journal-title":"Eur Thyroid J"},{"key":"2026022801264648000_oyag017-B138","doi-asserted-by":"publisher","first-page":"e240347","DOI":"10.1148\/radiol.240347","article-title":"2024 International expert consensus on US-guided thermal ablation for T1N0M0 papillary thyroid cancer","volume":"315","author":"Zhao","year":"2025","journal-title":"Radiology"},{"key":"2026022801264648000_oyag017-B139","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1007\/s00259-025-07222-1","article-title":"Chinese management guidelines for radioactive iodine-refractory differentiated thyroid cancer (2025 edition)","volume":"52","author":"Lin","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/advance-article-pdf\/doi\/10.1093\/oncolo\/oyag017\/66801415\/oyag017.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/31\/3\/oyag017\/66801415\/oyag017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/31\/3\/oyag017\/66801415\/oyag017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T06:26:56Z","timestamp":1772260016000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/doi\/10.1093\/oncolo\/oyag017\/8466638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":139,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2,5]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyag017","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,2,5]]},"article-number":"oyag017"}}